Patent details

EP2064246 Title: USE OF IL-23 ANTAGONISTS FOR TREATMENT OF INFECTION

Basic Information

Publication number:
EP2064246
PCT Application Number:
PCT/US/2008/001717
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP087142147
PCT Publication Number:
WO/2008/153610
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
USE OF IL-23 ANTAGONISTS FOR TREATMENT OF INFECTION
French Title of Invention:
UTILISATION D'ANTAGONISTES DE IL-23 POUR LE TRAITEMENT D'UNE INFECTION
German Title of Invention:
VERWENDUNG VON IL-23-ANTAGONISTEN ZUR INFEKTIONSBEHANDLUNG
SPC Number:

Dates

Filing date:
08/02/2008
Grant date:
22/05/2013
EP Publication Date:
22/05/2013
PCT Publication Date:
18/12/2008
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
03/06/2009
EP B1 Publication Date:
22/05/2013
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
08/02/2014
Expiration date:
08/02/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
08/02/2008
 
 

Name:
Merck Sharp & Dohme Corp.
Address:
126 East Lincoln Avenue, Rahway, NJ 07065-0907, United States (US)

Inventor

1

Name:
KASTELEIN Robert, A.
Address:
United States (US)

2

Name:
ROMANI Luigina
Address:
Italy (IT)

3

Name:
KOPF Manfred
Address:
Switzerland (CH)

4

Name:
CHACKERIAN Alissa, A.
Address:
United States (US)

Priority

Priority Number:
889475 P
Priority Date:
12/02/2007
Priority Country:
United States (US)

Classification

Main IPC Class:
C07K 16/28;
Filing date Document type Number of pages